Topics

Latest "Pharmaceutical Executive Conferences website" News Stories - Page: 2

10:18 EDT 17th September 2019 | BioPortfolio

Here are the most relevant search results for "Pharmaceutical Executive Conferences website" found in our extensive news archives from over 250 global news sources.

More Information about Pharmaceutical Executive Conferences website on BioPortfolio

In addition to our news stories we have dozens of PubMed Articles about Pharmaceutical Executive Conferences website for you to read. Along with our medical data and news we also list Pharmaceutical Executive Conferences website Clinical Trials, which are updated daily. BioPortfolio also has a large database of Pharmaceutical Executive Conferences website Companies for you to search.

Showing "Pharmaceutical Executive Conferences website" News Articles 26–50 of 16,000+

Tuesday 17th September 2019

Generium Launches First Biosimilar of Dornase Alfa; Becomes Sixth Approved Product Using Selexis SUREtechnology Platform

Selexis SA and Generium JSC today announced that a sixth Selexis SUREtechnology Platform™-generated biological product has been approved for marketing. The latest approved product, dornase alfa inhalation solution, is used together with antibiotics, b


2019 Aortic Aneurysm Clinical Trials Guide Companies, Drugs, Phases, Subjects, Current Status and Outlook to 2025 [Published by VPA Research] Prices from USD $1799

The global clinical trial report 2019 Aortic Aneurysm Clinical Trials Study provides complete list of trials completed, ongoing and planned for Aortic Aneurysm. It presents indepth analysis of Aortic Aneurysm clinical trials across markets and companies. The research work is for providing complete understanding into trends in Aortic Aneurysm. The report covers a key snapshot of trial trends, enro...

Anelto Health has announced its “Partnership for Better Outcomes” by releasing its new “No-Risk RPM Platform” for Remote Patient Monitoring

Anelto Health has announced its “Partnership for Better Outcomes” by releasing its new “No-Risk RPM Platform” for Remote Patient Monitoring (RPM) to hospitals and companies providing CCM and TCM to their patients. Anelto Health is a leader in the RPM space using a 2-way cellular hub and natural voice services to improve live communication and interaction with the patient for better outcome...


Flow Kana Launches First Docu-series Exclusively Focused on California’s Small Cannabis Farmers

“The Great Outdoor” Offers A Rare Look Into the Lives of Farmers Through the Seasons From Planting to Harvest Flow Kana, California’s number one selling cannabis flower brand, has debuted the first episode in a series of shorts that will be the first film series produced by a cannabis brand to highlight farmers. “The Great Outdoor” was filmed by David Zlutnick; Flow Kana co-founder Fla...

MedTech Strategist Announces Launch of New Publication Delivering Global Regulatory and Reimbursement Insights to the Medical Device Industry

MedTech Strategist Market Pathways: Global Regulatory, Reimbursement, and Policy Review is the go-to source to help industry make sense of the increasingly complex web of medtech market access policies worldwide MedTech Strategist, a leading information provider and investment conferences organizer focused exclusively on the rapidly evolving global medical device industry, is pleased to announce...

Instem Announces New Arrhythmia Module Featuring Leading-edge Machine Learning Technology to Aid Earlier Detection of Cardiac Risk

Instem Showcasing New Software Solution and Presenting Scientific Posters at this Year’s Safety Pharmacology Society Annual Meeting in Barcelona Instem, a leading provider of IT solutions to the global life sciences market is pleased to announce it will be exhibiting and presenting two posters at the 2019 Safety Pharmacology Society Annual Meeting (“SPS”), September 23–26 at the Centre d...

Certara Introduces Its Hasharc Decentralized Application for Healthcare at the Launch of Hedera Hashgraph Open Access

New Certara DApp provides transaction insights on Hedera network and supports data provenance for supply chain uses cases, improving transparency and disclosure for healthcare clients Certara®, the global model-informed drug development and decision support leader, today announced the launch of Hasharc, its decentralized applicatio

IVERIC bio to Present at the Ladenburg Thalmann 2019 Healthcare Conference

IVERIC bio, Inc. (Nasdaq: ISEE) announced today that Kourous A. Rezaei, MD, Chief Medical Officer of IVERIC bio, will present an overview of the Company at the Ladenburg Thalmann 2019 Healthcare Conference in New York on Tuesday, September 24, 2019 at 4:00 p.m. Eastern Time. Investors and the general public are invited to listen to a live webcast of the presentation on the Investor / Events &am...

Celsee Issued New Patent for Single-Cell Capture System

Company has been issued 10 patents in 2019 for its single-cell technology and key applications Celsee, Inc., today announced the issuance of U.S. Patent No. 10,416,070, entitled “Cell capture system and method of use,” which covers the automation of single-cell partitioning. Celsee has been issued ten patents by the U.S. Patent and Trademark Office (USPTO) in 2019, and now has a total of 30 ...

twoXAR Announces Appointment of Allen Poirson, Ph.D. as Senior Vice President of Biopharmaceutical Business Development

Industry veteran to drive partnerships to discover and develop first-in-class treatments for a wide range of diseases twoXAR, Inc., an artificial intelligence-driven biopharmaceutical company, today announced the appointment of Allen Poirson, Ph.D. as the company’s Senior Vice President of Biopharmaceutical Business Development. Dr. Poirson is an accomplished biotechnology industry executive w...

Seattle Genetics Announces Presentations of New Clinical Data from Multiple Studies of Novel Targeted Therapies at the European Society for Medical Oncology (ESMO) 2019 Congress

– First Presentation of Initial Data from a Phase 1 Trial of Enfortumab Vedotin Plus Pembrolizumab in Locally Advanced or Metastatic Urothelial Cancer Featured in an Oral Session – Seattle Genetics, Inc. (Nasdaq:SGEN) today announced that new data from four of its investigational programs will be presented at the upcoming European Society for Medical Oncology (ESMO) 2019 Congress in Barcelon...

EMA to provide guidance on avoiding nitrosamines in medicines

The EMA has announced it is drafting guidance on how to avoid the presence of nitrosamines, a probable carcinogenic ingredient, in drugs. The post EMA to provide guidance on avoiding nitrosamines in medicines appeared first on

2019 Myxoid Liposarcoma Clinical Trials Guide Companies, Drugs, Phases, Subjects, Current Status and Outlook to 2025 [Published by VPA Research] Prices from USD $1799

The global clinical trial report 2019 Myxoid Liposarcoma Clinical Trials Study provides complete list of trials completed, ongoing and planned for Myxoid Liposarcoma. It presents indepth analysis of Myxoid Liposarcoma clinical trials across markets and companies. The research work is for providing complete understanding into trends in Myxoid Liposarcoma. The report covers a key snapshot of trial ...

Three decades of pharmaceutical excellence: CPhI Worldwide

CPhI Worldwide will return for its 30th year on 5-7 November 2019 at Messe Frankfurt in Frankfurt, Germany. The post Three decades of pharmaceutical excellence: CPhI Worldwide appeared first on European Pharmaceutical Review.

Alpine Immune Sciences to Present at 2019 Ladenburg Thalmann Healthcare Conference

Alpine Immune Sciences, Inc. (NASDAQ:ALPN), a leading clinical-stage immunotherapy company focused on developing innovative treatments for cancer, autoimmune/inflammatory, and other diseases, today announced the company will present at the 2019 Ladenburg Thalmann Healthcare Conference on Tuesday, September 24, 2019 at 3:00 p.m. Eastern Time in New York, NY. A live webcast of the presentation wi...

Ontera Expands Executive Leadership Team as the Nanopore Diagnostics Company Advances Towards Product Commercialization

Former Google product lead Mark Rose to serve as VP of product management; Healthcare software development expert Raparti Swayambhu becomes VP of software Ontera, the leader in silicon-based nanopore diagnostics, today announced the appointments of Mark Rose as vice president of product management and Raparti Swayambhu as vice president of software. These two new members of the Ontera leadership...

Zhejiang Medicine Co Ltd 600216 Financial and Strategic SWOT Analysis Review [Published by Global Data] Prices from USD $125

Zhejiang Medicine Co Ltd 600216 Financial and Strategic SWOT Analysis Review provides you an indepth strategic SWOT analysis of the company's businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company's key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that au...

CO.DON AG: Negotiations on capitalization and out-licensing

DGAP-News: CO.DON AG / Key word(s): Miscellaneous 17.09.2019 / 11:18 The issuer is solely responsible for the content of this announcement. CO.DON AG - Negotiations on capitalization and out-licensing Berlin / Teltow, 17 September 2019 - As a result of the evaluation of various financing options to secure the capital required by CO.DON AG to implement its corporate strategy,...

2019 Cholelithiasis Clinical Trials Guide Companies, Drugs, Phases, Subjects, Current Status and Outlook to 2025 [Published by VPA Research] Prices from USD $1799

The global clinical trial report 2019 Cholelithiasis Clinical Trials Study provides complete list of trials completed, ongoing and planned for Cholelithiasis. It presents indepth analysis of Cholelithiasis clinical trials across markets and companies. The research work is for providing complete understanding into trends in Cholelithiasis. The report covers a key snapshot of trial trends, enrollme...

2019 Myeloid Metaplasia Clinical Trials Guide Companies, Drugs, Phases, Subjects, Current Status and Outlook to 2025 [Published by VPA Research] Prices from USD $1799

The global clinical trial report 2019 Myeloid Metaplasia Clinical Trials Study provides complete list of trials completed, ongoing and planned for Myeloid Metaplasia. It presents indepth analysis of Myeloid Metaplasia clinical trials across markets and companies. The research work is for providing complete understanding into trends in Myeloid Metaplasia. The report covers a key snapshot of trial ...

Advantum Health’s Med Advantage Subsidiary Receives NCQA Certification for All 11 Credentials Verification Categories

NCQA recertification reaffirms company’s ongoing commitment to credentialing best practices Advantum Health™, a leader in revenue cycle management and credentialing services for healthcare providers, h

ArQule to Participate in the Oppenheimer Fall Summit Focused on Specialty Pharma and Rare Disease Companies on September 24, 2019

ArQule, Inc. (Nasdaq: ARQL) today announced that Paolo Pucci, Chief Executive Officer, and Dr. Brian Schwartz, Chief Medical Officer and Head of Research and Development, will participate in the Oppenheimer Fall Summit Focused on Specialty Pharma and Rare Disease Companies on Tuesday, September 24, 2019 at The Parker New York Hotel in New York City. About ArQule ArQule is a biopharmaceutical...

Concert Pharmaceuticals Completes Enrollment in Second Open Label Trial of CTP-543 to Evaluate Once-Daily vs. Twice-Daily Dosing in Patients with Alopecia Areata

Concert Pharmaceuticals, Inc. (NASDAQ: CNCE) today announced that it has completed patient enrollment of an open label clinical trial to evaluate once-daily 24 mg compared to twice-daily 12 mg oral dosing of CTP-543 in patients with alopecia areata. Topline data from this dose regimen trial is expected in the first half of 2020. “We are extremely grateful to the patients who volunteer to part...

2019 Cardiogenic Shock Clinical Trials Guide Companies, Drugs, Phases, Subjects, Current Status and Outlook to 2025 [Published by VPA Research] Prices from USD $1799

The global clinical trial report 2019 Cardiogenic Shock Clinical Trials Study provides complete list of trials completed, ongoing and planned for Cardiogenic Shock. It presents indepth analysis of Cardiogenic Shock clinical trials across markets and companies. The research work is for providing complete understanding into trends in Cardiogenic Shock. The report covers a key snapshot of trial tren...

Zymeworks Announces New Chair of Board of Directors and Voluntary Delisting from the TSX

Zymeworks Inc. (NYSE/TSX: ZYME), a clinical-stage biopharmaceutical company developing multifunctional biotherapeutics, announced that Lota Zoth has been appointed as its Chair of the Board of Directors. Ms. Zoth succeeds Nick Bedford, who has retired from his functions as Chair and Board member. Mr. Bedford served as Board Chair since September 2004. “Lota has provided valuable insights and ...


Quick Search

News Quicklinks